MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Clinical trials for MALIGNANT GENITOURINARY SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT GENITOURINARY SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT GENITOURINARY SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat urinary cancers
Disease control OngoingThis early-phase study tests a combination of two or three drugs (cabozantinib, nivolumab, and sometimes ipilimumab) in people with advanced genitourinary cancers that have spread. The main goals are to find the safest doses and understand side effects. About 152 adults with vari…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for immunotherapy side effects: which drug works best for colitis?
Disease control OngoingThis study compares two medications, infliximab and vedolizumab, to treat colitis (colon inflammation) caused by immune checkpoint inhibitor therapy in cancer patients. About 47 adults with genitourinary cancer, melanoma, or non-small cell lung cancer are participating. The goal …
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC